Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS

Aurora Cannabis (NASDAQ:ACB) issued its quarterly earnings results on Wednesday. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.11 by ($0.04), Zacks reports. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%.

Aurora Cannabis Trading Down 4.4%

NASDAQ ACB opened at $5.88 on Wednesday. The company has a current ratio of 3.30, a quick ratio of 1.60 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 1-year low of $3.42 and a 1-year high of $7.20. The firm’s fifty day simple moving average is $5.04 and its 200-day simple moving average is $4.74. The company has a market capitalization of $330.51 million, a PE ratio of 117.62 and a beta of 1.82.

Institutional Trading of Aurora Cannabis

An institutional investor recently raised its position in Aurora Cannabis stock. Goldman Sachs Group Inc. lifted its holdings in Aurora Cannabis Inc. (NASDAQ:ACB) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 743,903 shares of the company’s stock after purchasing an additional 29,099 shares during the period. Goldman Sachs Group Inc. owned 1.32% of Aurora Cannabis worth $3,266,000 as of its most recent filing with the SEC. 47.63% of the stock is currently owned by hedge funds and other institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.